Reference health
Recent advances in the diagnosis and management of pre-eclampsia
49/49 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 49 checked references that resolve
resolves10.1016/j.preghy.2014.02.001
The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP
resolves10.1002/14651858.CD004659.pub2
Antiplatelet agents for preventing pre-eclampsia and its complications
resolves10.3945/ajcn.116.130419
Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status
resolves10.1017/S0007114516003202
The relationship between 25-hydroxyvitamin D concentration in early pregnancy and pregnancy outcomes in a large, prospective cohort
resolves10.1111/1471-0528.12613
Low‐dose calcium supplementation for preventing pre‐eclampsia: a systematic review and commentary
resolves10.1016/j.preghy.2015.04.001
The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: An exploratory, randomized placebo controlled study
resolves10.1016/j.ajog.2014.07.052
Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia
resolves10.1038/jp.2013.176
Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes
resolves10.1515/jpm-2013-0298
Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin
resolves10.1016/j.ajog.2013.11.012
Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes
resolves10.1111/1471-0528.12128
Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre‐eclampsia in a low‐risk nulliparous patient population?
resolves10.1515/cclm-2013-0338
First trimester pregnancy-associated plasma protein A and human chorionic gonadotropin-beta in early and late pre-eclampsia
resolves10.1111/1471-0528.13334
Quality of first trimester risk prediction models for pre‐eclampsia: a systematic review
resolves10.1007/s40291-016-0245-9
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis
resolves10.1111/1471-0528.14029
The performance of risk prediction models for pre‐eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review
resolves10.1080/10641950802601286
Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home
resolves10.1111/j.1471-0528.2000.tb11692.x
Antenatal home blood pressure monitoring: a pilot randomised controlled trial
resolves10.1136/bmj.325.7358.258
Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care
resolves10.1002/14651858.CD001231
Ambulatory versus conventional methods for monitoring blood pressure during pregnancy
resolves10.1186/ISRCTN16018898
OPTIMUM: Optimising Titration and Monitoring of Maternal Blood Pressure
resolves10.1080/10641950500281019
Urine Protein Estimation in Hypertensive Pregnancy: Which Thresholds and Laboratory Assay Best Predict Clinical Outcome?
resolves10.1136/bmj.e4342
Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis
resolves10.1097/AOG.0000000000001042
The Utility of 12-Hour Urine Collection for the Diagnosis of Preeclampsia
resolves10.1161/CIRCULATIONAHA.113.003215
Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia
resolves10.1056/NEJMoa1414838
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
resolves10.3111/13696998.2010.535285
Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective
resolves10.1371/journal.pone.0164276
Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis
resolves10.1002/uog.15997
sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK
resolves10.1038/ncb1596
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
resolves10.1016/j.cca.2011.07.029
Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women
resolves10.1111/j.1582-4934.2011.01291.x
Elevated levels of hypoxia‐inducible microRNA‐210 in pre‐eclampsia: new insights into molecular mechanisms for the disease
resolves10.1210/jc.2017-00672
Placental Exosomes as Early Biomarker of Preeclampsia: Potential Role of Exosomal MicroRNAs Across Gestation
resolves10.1111/1471-0528.12737
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review
resolves10.1111/1471-0528.13463
Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta‐analysis
resolves10.1002/14651858.CD003106.pub2
Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation
resolves10.1016/S0140-6736(14)61998-X
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial
resolves10.1186/ISRCTN01879376
PHOENIX - Pre-eclampsia in HOspital: Early iNductIon or eXpectant management
resolves10.1016/S0140-6736(13)60686-8
Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study
resolves10.1161/HYPERTENSIONAHA.114.04850
Cardiovascular Disease Risk Factors After Early-Onset Preeclampsia, Late-Onset Preeclampsia, and Pregnancy-Induced Hypertension
resolves10.1016/j.ajog.2016.02.003
A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later
The 5 references without a DOI — listed, not checked
no DOI — not checkedThe World Health Report 2005: Make every mother and child count
no DOI — not checkedPerinatal Mortality 2008
no DOI — not checkedBlood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension (BUMP)
no DOI — not checkedDAPPA Protocol: Spot Protein Creatinine Ratio (SPCr) and Spot Albumin Creatinine Ratio (SACr) in the Assessment of Pre-Eclampsia: A Diagnostic Accuracy Study with Decision Analytic Model Based Economic Evaluation and Acceptability Analysis
no DOI — not checkedMBRRACE-UK: Saving Lives, Improving Mothers' Care
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.12688/f1000research.12249.1"><img src="https://citestamp.com/citestamped/10.12688/f1000research.12249.1/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.12688/f1000research.12249.1)